Naturally occurring mutations of the extracellular Ca2+-sensing receptor: Implications for its structure and function

Trends in Endocrinology and Metabolism

Volumn 14, Issue 6, 2003, Pages 282-288

  Hu, Jianxin ^a   Spiegel, Allen M ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; G PROTEIN COUPLED RECEPTOR; METABOTROPIC RECEPTOR;

ALLOSTERISM; AUTOSOMAL DOMINANT DISORDER; DIMERIZATION; EXTRACELLULAR CALCIUM; GENE MUTATION; GENE SEQUENCE; HYPERCALCEMIA; HYPOCALCEMIA; HYPOCALCIURIA; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; RECEPTIVE FIELD; RECEPTOR AFFINITY; REVIEW; SEQUENCE ANALYSIS;

EID: 0042233567     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00104-8     Document Type: Review

References (43)

1. Brown, E.M. et al. (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366, 575-580
2. Brown, E.M. and MacLeod, R.J. (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 81, 239-297
3. Brown, E.M. et al. (1998) The extracellular calcium-sensing receptor: its role in health and disease. Annu. Rev. Med. 49, 15-29
4. 2+ receptor from brain to gut: common stimulus, diverse actions. Trends Endocrinol. Metab. 9, 354-359
5. Nemeth, E.F. and Fox, J. (1999) Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism. Trends Endocrinol. Metab. 10, 66-71
6. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J. Pharmacol. Exp. Ther. 299, 323-331
7. Bockaert, J. and Pin, J.P. (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729
8. Palczewski, K. et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745
9. Kunishima, N. et al. (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971-977
10. 2+ sensing receptor. Trends Pharmacol. Sci. 21, 401-407
11. Ray, K. et al. (1998) Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J. Biol. Chem. 273, 34558-34567
12. Goldsmith, P.K. et al. (1999) Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J. Biol. Chem. 274, 11303-11309
13. 2+ receptor extracellular domain. Analysis of function of lobe I loop deletion mutants. J. Biol. Chem. 276, 32145-32151
14. 136 region in the calcium-sensing receptor. J. Biol. Chem. 275, 29547-29555
15. 2+ receptors. Mol. Pharmacol. 55, 642-648
16. Brauner-Osborne, H. et al. (1999) The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J. Biol. Chem. 274, 18382-18386
17. 2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors. J. Biol. Chem. 275, 16382-16389
18. 2+ receptor activation. Endocrine 13, 63-70
19. Zhang, Z. et al. (2002) Three adjacent serines in the extracellular domains of the CaR are required for L-amino acid-mediated potentiation of receptor function. J. Biol. Chem. 277, 33727-33735
20. 2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett. 436, 353-356
21. Tsuji, Y. et al. (2000) Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 275, 28144-28151
22. 3+. Proc. Natl. Acad. Sci. U. S. A. 99, 2660-2665
23. Sato, T. et al. (2003) Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1: identification of crucial residues for setting the activated state. J. Biol. Chem. 278, 4314-4321
24. Zhang, Z. et al. (2001) The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J. Biol. Chem. 276, 5316-5322
25. 2+ receptor. J. Biol. Chem. 274, 27642-27650
26. Bai, M. et al. (1999) Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc. Natl. Acad. Sci. U. S. A. 96, 2834-2839
27. Hu, J. et al. (2001) The Venus's-flytrap and cysteine-rich domains of the human Ca2+ receptor are not linked by disulfide bonds. J. Biol. Chem. 276, 6901-6904
28. 2+ and a positive allosteric modulator. J. Biol. Chem. 277, 46622-46631
29. Vlaeminck-Guillem, V. et al. (2002) Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16, 736-746
30. Ray, K. et al. (1997) The carboxyl terminus of the human calcium receptor: requirements for cell-surface expression and signal transduction. J. Biol. Chem. 272, 31355-31361
31. 2+ activation of the human calcium sensing receptor. A study with receptor-green fluorescent protein fusions. J. Biol. Chem. 273, 29712-29718
32. Hjalm, G. et al. (2001) Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J. Biol. Chem. 276, 34880-34887
33. Yamauchi, M. et al. (2002) Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene. J. Bone Miner. Res. 17, 2174-2182
34. Hendy, G.N. et al. (2000) Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum. Mutat. 16, 281-296
35. D'Souza-Li, L. et al. (2002) Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J. Clin. Endocrinol. Metab. 87, 1309-1318
36. Vargas-Poussou, R. et al. (2002) Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13, 2259-2266
37. Watanabe, S. et al. (2002) Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360, 692-694
38. Lienhardt, A. et al. (2000) A large homozygous or heterozygous inframe deletion within the calcium-sensing receptor's carboxyl terminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J. Clin. Endocrinol. Metab. 85, 1695-1702
39. 2+ receptor. FEBS Lett. 448, 180-184
40. Cohen, A. and Silverberg, S.J. (2002) Calcimimetics: therapeutic potential in hyperparathyroidism. Curr. Opin. Pharmacol. 2, 734-739
41. Zhang, Z. et al. (2002) L-Phenylalanine and NPS R-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites. J. Biol. Chem. 277, 33736-33741
42. Gasparini, F. et al. (2002) Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2, 43-49
43. Malherbe, P. et al. (2003) Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, non-competitive antagonist of the metabotropic glutamate 1 receptor. J. Biol. Chem. 278, 8340-8347